Evidence-Based Compounds for Depression
Depression involves disrupted monoamine signalling, neuroinflammation, impaired neuroplasticity, and HPA axis dysregulation. Multiple natural compounds show clinical evidence for improving depressive symptoms through serotonin reuptake modulation, BDNF upregulation, anti-inflammatory action, and cortisol normalisation — with growing evidence from RCTs.
This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.
Browse all compounds · Biological pathways · Molecular targets · All conditions
© Organiq Sweden AB · Patent pending EVE-PAT-2026-001